Connect with us

Cannabis News

Wisconsin GOP Assembly Speaker Hopes For ‘Consensus’ On Medical Marijuana, But Says New Senate Bill Is ‘Too Broad’

Published

9 months ago

on

Wisconsin’s GOP Assembly The Legitius pointed out to legislators in the state “I can find agreement to legalize medical marijuana. But he added that The new Cannabis Bill presented Billpart of his Leadership in the Senate It is “unlikely” to exceed his chamber “is a broad and extensive way.”

“I’ve tried for five or six years” Loudspeakers Robin Vos (R) I said speaker on a conversation with Wisn-Tv on Sunday. “The idea that we will have medicine dispensers in all cities around the state, I don’t know where most people are.”

Last year, VOS restricted a medical channel bill Asked a limited program through state discourses.

“So we tried to be a much more limited version,” Let’s look at five or six discharge Americans (and) to help people who are not actually sick of diagnosis, “he said in the new interview.

But the model of the state had a controversial among his Republican colleagues, and suddenly stopped. Now, Vos last week’s President Mary Felzkowski (R) and GOP Legislature will be emerging concerns about new legislation included in other traditional protection systems.

“I still think it’s like trying to find agreement, but it’s like a version that was released, people worrying that people will bring leisure marijuana.” “I don’t want that.”

The speaker said it was “unlikely” that the Senate bills could be cleaned enough to clean the assembly.




“There is a whole group of Republic I understand, because they think it will be out of the recreation marijuana, that it would be horrible for Wisconsin,” he said. “There is another group that wants to legalize marijuana, and they are democrats, so they don’t want to be a real restriction.”

“So it’s very difficult to try to find the central consensus, and that’s why I thought it was a very scale, aimed at people who were really sick and poor. However, it will not be seen in a scenario.”

Asked the new bill of Senate boss, vos celurbill “Probably” should not be reached.

Last week, Felzkowski (R), previously supported another project in Cannabis Bill. Patrick testin (r) Sen. R) presented a new measure.

The text of the proposal was not immediately available, but Felzkowski would have previously invoices Doctors allow patients to issue medical cannabis recommendations One of eight conditions, including cancer, seizure disorders, traumatic stress cover and multiple sclerosis.

Legislation was relatively restrictive because the prohibited marijuana products were banned and did not raise their patients for personal authorization. Patients could only get cannabis preparations for oil, tablets, inkjet or topical.

“Someone who suffers a serious health condition should not be chance to travel to another state or break the law, try alternative medicine for relief,” said Felzkowski in a press release.

“This legislation is about providing a chronic disease to our friends, family members and neighbors, the freedom to study another chance with the doctor,” he said. “It is also possible for our small business businesses to participate in this market with reasonable regulations for making and selling products, all protecting public security.”

Session 2025 was launched, Senate’s leader said He hopes to have a dialogue in legislature on legalization of medical marijuana This year, however, the speaker of the assembly, he still imagined “obstacles”.

Meanwhile, the Republican candidate for governor Wisconsin said in July “Considering different options” was open “marijuana when they use doctors or adults In the state, even if he has given few ways to the specification so far.

Democratic side, today’s Gov. Tony never (d), which supports legalization of cannabis, is not again looking for elections. But he said in June When his party can take control of the legislature, the state may legalize the “Eventually” marijuana Residents should not go to the side of Illinois to visit adult use in the market.

In June, a survey of Marquette Law School discovered Two wisconsin voters help legalize marijuana.

The survey found the support for cannabis reform, usually since the organization has first started, since the continued public opinion of legalization in 2013, 67% of the voters protect the policy change. That’s 17% higher than the results of 2013.

Democrats are the best legalizing cannabis, in 88 percent, and then independent (79 percent). However, most Republicans (56 percent) said they are against the legalization of adults.

Emphasize the importance of the party control, the Senate of the State Senate Republic and the Assembly rejected another attempt to legalize marijuana this summer, Defeating corrections of the budget legislation that would end the State Prohibition And he established new programs for cannabis medical and recreation programs.

Ever This policy attempted to change as part of his budget requests-And democratic leaders have also been promoted to reform.

Republicans in legislature Also cut the provisions of marijuana from the state budget proposal in Mayas they did in past sessions.

Although Republicans move from the legalization of the budget legislation, Party leaders recently recognized the debate about medical marijuana legalization “that will not leave” And this session is expected to be resolved.

–
Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.

Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.
–

“I don’t think anyone marijuana and thc products are not believed that marijuana and thc products are not available when they are available in line lines, so I think we need to get to an answer about this,” the leader of the General Assembly. Tyler said August (r) in February. “I hope we can.”

“We will call the marijuana doctor if we have to be treated as pharmacy. But the marijuana discussion will be something that will leave,” Dan Feyen (R), the Majority Assistant said at the time. “Margins are more closely.”

Provided his intention as long as he previews January into Marijuana LegalizationWhile the residents of the State must propose new laws, putting binding questions about linking chanabis reform, being able to enjoy the support of Bipartis, has repeatedly refused the GOP-controlled legislature.

Before, in 2022, the governor signed a corrective order with a specific goal of calling a special legislature give people right to dispose of citizen initiativesElectrations of cannabis to decide to collect expectations among the advocates that the voters could decide. The GOP legislature did not take the proposal, however.

He never said in December Marijuana reform is one of the key priorities that the State should move forward In the 2025 session, the legislator works with a quote surplus.

Notes after making a The survey was found to be welcome by reform voters in the countryside of state. Almost two-thirds (65 percent) said they accept the legalization of cannons.

In the end, the governor said that the “promising” was partly that the November 2024 election would bring democratic control of the legislature Argued that he would locate the statue to legalize cannabis.

“We worked hard in the last five years, several budgets, to happen,” he said at the time. “I know we are surrounded by states of recreation marijuana, and we will continue to do that.”

The Democratic Assembly of Wisconsin tried to force a medical commitment proposal in Cannabis, as the correction of a cratom Bill, but the Maryhuana moment said he suspects leadership He intentionally did this legislation from the agenda to avoid the show about the subject.

Meanwhile, the state income was released a tax estimate of the tax estimation since then – Estimation of the economic impact of the Sen’s economic impact. In 2023 Melissa Agard (D) by projecting that Reform would generate almost $ 170 million in case of tax revenues every year.

An estimated legislature requested by legislators Wisconsin residents spent more than $ 121 million in Illinois Canavies only In 2022, contributing $ 36 million in terms of adjacent situations.

Never and other Democrats have had at least in January The Marijuana Medical program stresses that they will be willing to taste the shelfEven if they preferred a more comprehensive reform.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

Entourage Health, formerly WeedMD, enters creditor protection

Published

7 hours ago

on

June 30, 2026

By

Entourage Health Corp. has entered creditor protection. The company and six related entities filed on June 17 under the Companies’ Creditors’ Arrangement Act owed approximately $240.1 million to the sole affiliate of the LiUNA Pension Fund, its owner, its secured creditor and the lender that is now funding the money (First Report pp. 3-6-9

That affiliate, 2437653 Ontario Inc. No. 1 company, Entourage, secured a 2024 deal that took the former WeedMD private and off the TSX Venture Exchange (December 2024 PR). Shareholders were paid half a Canadian cent per share, or C$0.005, and the board recommended a sale in December 2024 (December 2024 PR).

Jason Alexander, head of the special committee of independent directors, recommended to shareholders. “The transaction ensures that shareholders will receive immediate tangible value while positioning the Company for future growth and flexibility,” Alexander said (December 2024 PR). The company took on $167.6 million in debt in that sale, having already breached the covenant with the same guarantee (December 2024 PR). Eighteen months later that debt was $240.1 million when it was filed, and the growth promised by the sale is a settlement (First Report 6-18 p.

Adult use is off, medical is still running
The leisure business is closing, not saving. Entourage laid off about 53 workers in early June before the order, and 22 remain (First Report p. 6 Adult use inventory is being cleared, finished products are shipped to provincial distributors, and flowers are sold in bulk to the market to other licensed growers (First Report p. 12 Color Cannabis, Dime Bag and Saturday Cannabis are the brands going down with it (First Report p. 5

What remains open is the doctor’s arm as the exclusive supplier of cannabis under the Starseed brand to local residents of the Workers International Union of North America (First Report p. 5 The pension fund that funds the procedure is tied to the same union that the medical brand serves, and the part of Entourage that serves union members is the part that is kept alive while the rest is sold for parts.

At the end of July the money runs out with no new money (First Report p. 11 The money comes again from the pension fund affiliate, a $1.1 million debtor-in-possession facility at 5% per annum, no commitment fee, no exit fee (First Report pp. 10-11). The monitor, Ernst & Young, checked terms against other DIP loans in the cannabis sector from January 2024 and concluded that a third-party lender would not lend on better terms given the state of the business (First Report p. 11 The lender, which already owed $240 million, is the only one willing to advance another million to keep the lights on through the sale.

Health Canada is the largest unsecured creditor, owed $494,505, ahead of all suppliers and competitors on the company’s books (List of Creditors p. 1 Supreme Cannabis is owed $262,133, medical platform HelloMD is owed $169,564, the Town of Aylmer is owed $144,815, the Independent Retail Cannabis Board is owed $137,098 and High Tide is owed $124,583 (List of Creditors p. 1 Unsecured claims total $3,288,333 in more than 100 names, many of which have yet-to-be-determined amounts by medical clinics (List of Creditors 1-5 p. Against $240 million guaranteed, none of them will see much.

In the June 29 return, the lender asks the judge to extend the stay until August 28, approve the DIP facility, and double the Administrative and Directors fees to $500,000 each (First Report 4-8-12. p. The directorship is rising as directors face payroll, holiday pay and excise duties over a longer period of time, and the company’s directors and officers insurance expires at the start of July (First Report p. 12

The sales process starts on the same day, based on a marketing effort that started around May and was presented before the deal that sparked interest but no one could make a deal (First Report p. 13 Insiders and affiliates have until July 6th to say they intend to bid, the bid deadline is July 30th, the successful bid must be received by August 7th, and the outside deadline is August 28th (First Report p. 15 The affiliate of the pension fund has written to the Monitor that it will not make an offer (First Report p. 16), and any other affiliate that does so must be removed from the process (First Report p. 16 The settlement request for non-cannabis equipment and the sale of the Aylmer facility, a 26,000-square-foot extraction and processing facility that has been the company’s production base at 250 Elm St.

the source

For more information:
Neighborhood Health
1.844.933.3636
(email protected)
entouragehealthcorp.com

Continue Reading

Cannabis News

DEA And FDA Highlight How Marijuana Is Safer Than Alcohol And Opioids During Rescheduling Hearing’s Opening Day

Published

7 hours ago

on

June 30, 2026

By

Attorneys for the Drug Enforcement Administration (DEA) on Monday highlighted testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids in the opening day of a hearing. The Trump administration’s cannabis rescheduling proposal.

Marijuana Moment spoke with several people in the audience for Monday’s hearing to find out how the testimony is going, despite the proceedings not being broadcast live to the public at the request of one congressman and others.

According to those sources, DEA attorney James J Schwartz stated that the government is the proponent of the proposed rule to formally move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), stating that the hearing is “not about the recreational use of marijuana” and “about regulation, not about legalization.”

“The government has presented no evidence to suggest that marijuana is not dangerous. All controlled substances are dangerous,
he said “However, controlled substances must be evaluated against the risks they pose, balanced against the medical benefits they provide.”

Dominic Chiapperino, director of the Food and Drug Administration’s Center for Controlled Drug Evaluation and Research and one of two DEA witnesses, testified about how federal health officials formed their recommendation to reschedule cannabis.

Opponents of the reform have used a new two-part test that they argue is a bad departure from a previous analysis, although a DEA lawyer said the hearing is not about that issue, and Chiapperino said the new test is now considered “every time” a new analysis is done on a drug.

The FDA official said the agency compared marijuana to alcohol, opioids and other substances in its scheduling analysis, and found that marijuana’s daily harms were lower than all or most of those comparators.

Cannabis is associated with fewer overdose deaths than comparable substances, Chiapperino said, and when reports of cases involving deaths mention marijuana, the deaths are often attributed to secondary incidents such as accidents or self-inflicted harm. Marijuana’s potential for overdose deaths is “much lower” than other Schedule I drugs and Schedule II drugs. Rather than opioids, the FDA official said.

As for withdrawal in regular users, Chiapperino testified that cannabis has symptoms similar to tobacco, including irritability, but alcohol has “more of a withdrawal syndrome,” which can include seizure and death.

Also on Monday, the lawyers of some of the parties against the reorganization had the opportunity to cross Chiapperino.

Kevin Sabet, president and CEO of the prohibitionist organization Smart Approaches to Marijuana, who was also invited to attend the hearing, said in a video posted on social media that it is “surreal” to see the government arguing that cannabis’s medical uses and relatively minor harms are “just lying through their teeth.”

The DEA “is in a very awkward position to argue the opposite of what it’s been arguing for the last 50 years, the opposite of what the science says, the opposite of what the evidence is,” he said, “which is, of course, to argue against the government that marijuana is more harmful than we thought, not less harmful.”

On Tuesday, opponents of the review will have an opportunity to cross-examine the FDA official, and the government’s second witness, Corey Burchman, a doctor from New Hampshire, will begin his testimony. The DEA announced in a filing last week that it will do so Testify on “How Medical Marijuana Provides Medical Benefit to Pain Patients.”

On Monday, a DEA attorney said Burchman would “describe the real-world impacts of treating pain with marijuana instead of opioids” based on his experience with both and discuss how he has “personally transitioned patients from opioids to marijuana for their pain.”

The witness will also testify about the differences between cannabis and opioids in terms of withdrawal and overdose, he said.

Before the hearing began, marijuana reform activists rallied They held a press conference outside DEA headquarters to highlight how they feel of the process – criticizing the fact that supporters of the reform were not invited to participate and that the proceedings are not reproduced live, despite the “transparency” oath of the officials.

DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling followers that they do not meet the definition of “interested person” to participate because they are not “affected or prejudiced by any rule or proposed rule that may be issued.”

last week, Marihuana Moments sent petitions to DEA Chief Administrative Law Judge Derek Julius and DEA Administrator Cole asking for them reverse the decision to ban the public from tuning into the cannabis hearing via live stream. A Congressmen and other journalists later joined that request.

—
Marijuana Moment’s journalism is made possible by readers like you, who value this work enough to support us Patreon Monthly Pledges. If you rely on our reports to stay informed of important developments in cannabis, please help us do this becoming a permanent subscriber today.

Backed by us at the $25/month level, you’ll have access to our Bill Tracker so you don’t miss any important marijuana legislation in your state.
—

The opponents who are participating in the hearing submitted statements last week anticipate the anti-marijuana arguments they intend to make during the procedure.

The hearing it will end before July 15.

Acting Attorney General Todd Blanche in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA).

According to a separate order signed by the acting attorney general, the upcoming hearing will include Class III marijuana.

Preliminary hearing process on the marijuana redistricting process initiated by the Biden administration It was halted last year amid allegations of improper communications and witness selection.

the current The marijuana redistricting process is being challenged in several ways which have been upheld by a federal Court of Appeals. those pieces of State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

Meanwhile, the reorganization of state-licensed medical cannabis is already having a major impact.

The Congressional Research Service published a report on the current rescheduling of cannabis Certified patients with medical marijuana from state licensed dispensaries are now eligible for Class III. “The order appears to allow end users to use marijuana medically without a CSA prescription,” he says.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has published a Draft update to a gun purchase form to recognize the legal status of medical marijuana in the reprogramming. The revised section of the question states that only the “recreational use or possession of marijuana” is federally prohibited, omitting the prior form’s mention of medical cannabis.

The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

Even the DEA, which has long opposed cannabis legalization and accused the Biden administration of stalling the initiative in the reorganization process, has done so. It launched a registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.

The Department of Transport, on the other hand, issued guidelines stating this use Legal medical cannabis in the state is still no excuse for truck drivers to test positive for drugspilots and other safety-sensitive personnel.

A congressional committee recently Federal officials voted to block further steps to reschedule cannabishowever lawmakers from both parties told Marihuana Moment they don’t think that provision will be enacted become law

user photo Carlos Gracia.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

cbdMD welcomes White House call for fair treatment of hemp-derived products

Published

1 day ago

on

June 29, 2026

By











cbdMD welcomes the Administration’s call for Congress to ensure fair treatment of hemp-derived products under federal law and calls for immediate action to revise hemp regulations to ensure fair treatment of hemp products under federal law.

In a letter to congressional leadership this week, the White House Office of Management and Budget identified hemp reform as a priority strongly supported by the Administration. The petition calls on Congress to ensure fair treatment of hemp-derived products by maintaining access to appropriate full-spectrum CBD products, and by maintaining Congress’ intent to reduce products that pose health risks. The administration also urged Congress to pass a responsible federal framework or at least extend the current implementation period to give lawmakers time to get policy right. The request builds on the president’s previous public statements urging lawmakers to protect access to full-spectrum CBD products that millions of Americans rely on.

“We are encouraged to see the administration so clearly championing the responsible, scientific hemp products that consumers depend on every day,” said Ronan Kennedy, CEO of cbdMD. “cbdMD has always believed that the future of this category is built on quality, transparency, and clear rules that separate them from bad actors. A federal framework that protects consumer access, promotes safety, and provides certainty to companies that provide certainty is what this industry and the people it serves deserve. We applaud the policymakers who are working to achieve this outcome.”

“We believe CbdMD is purpose-built for this next phase of the market,” added Kennedy. “Our focus remains on serving our customers with reliable and effective products, supporting responsible regulation and building long-term value for our shareholders as the category continues to evolve. Along the way, we will continue to evaluate the opportunities this evolving environment holds.”

For more information:
cbdMD
cbdmd.com/










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media